Ultralife Q1 Revenue Falls 6.5%, Posts Net Loss; Record Backlog Offers 2026 Hope
Summary
Ultralife Corp reported a 6.5% year-over-year decline in Q1 revenue to $47.45 million, resulting in a net loss of $471,000. The company attributed the weak performance to operational disruptions, including lost production days and order delays, particularly in its Communications Systems segment, alongside higher operating expenses. This immediate negative financial performance is material for the company. However, Ultralife also announced a record backlog of $115.1 million, up from Q4 2025, which it believes positions it to restore profitability and generate cash flow in 2026. Traders will be closely watching for the company's ability to execute on this backlog and resolve the production and order delay issues to achieve its stated outlook for the remainder of the year.
At the time of this announcement, ULBI was trading at $6.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $117.4M. The 52-week trading range was $4.50 to $9.52. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.